The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Elliott Russell P. since year 2005.
The trader's CIK number is 1727807.
At the time of this reporting, Elliott Russell P. is the VP Drug Development of Foamix Pharmaceuticals Ltd. .
(stock ticker symbol FOMX).
See this page for all insider trading activities at Foamix Pharmaceuticals Ltd. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-07-02||FOMX||Foamix Pharmaceuticals Ltd.||Sale||142||5.10||724|
|2018-04-02||FOMX||Foamix Pharmaceuticals Ltd.||Sale||142||5.08||721|
|2018-03-02||FOMX||Foamix Pharmaceuticals Ltd.||Sale||817||6.14||5,016|
|2018-01-01||FOMX||Foamix Pharmaceuticals Ltd.||Option Ex||1,372||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Elliott Russell P. (VP Drug Development of Foamix Pharmaceuticals Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.